Rockwell Medical Technologies (RMTI) Posts Q3 Loss of $0.28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $6.94 -1.7%
Revenue Growth %: +14.9%
Financial Fact:
Selling, General and Administrative: 5.07M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +14.9%
Financial Fact:
Selling, General and Administrative: 5.07M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $11.98 million versus the consensus estimate of $12.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- GrafTech International Ltd. (EAF) Misses Q3 EPS by 39c
- Balchem Corp. (BCPC) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
